Ipamorelin + CJC-1295 Stack: Growth Hormone Research Guide 2026

Peptod13 min read
Share:
Ipamorelin + CJC-1295 Stack: Growth Hormone Research Guide 2026

Understanding the Ipamorelin + CJC-1295 Stack

The combination of Ipamorelin and CJC-1295 represents one of the most studied peptide stacks for growth hormone (GH) research. By combining a growth hormone releasing peptide (GHRP) with a growth hormone releasing hormone (GHRH) analog, researchers can examine synergistic effects on the GH axis.

This stack exploits two distinct pathways: Ipamorelin initiates GH pulses through the ghrelin receptor, while CJC-1295 amplifies these pulses through the GHRH receptor. The result is potentially greater and more physiological GH release than either peptide alone.

How the Stack Works

Two Distinct Pathways

Ipamorelin (GHRP):

  • Activates ghrelin receptor (GHS-R1a)
  • Initiates GH release from somatotrophs
  • Creates the "pulse" signal
  • Fast-acting, short duration
  • CJC-1295 (GHRH analog):

  • Activates GHRH receptor
  • Amplifies GH release amplitude
  • Extends duration of pulse
  • Longer-acting effects
  • Synergy Mechanism

    When combined:

  • Ipamorelin binds GHS-R → Initiates GH secretion
  • CJC-1295 binds GHRH-R → Amplifies response
  • Different pathways → Additive/synergistic effect
  • Result → Greater GH release than either alone
  • This mimics natural physiology where ghrelin and GHRH work together.

    Component Profiles

    Ipamorelin

    PropertyDetails
    TypeGrowth Hormone Releasing Peptide
    ReceptorGhrelin receptor (GHS-R1a)
    Amino Acids5 (pentapeptide)
    SelectivityHigh (GH-specific)
    Cortisol EffectMinimal
    Prolactin EffectMinimal
    Appetite EffectMinimal

    Why Ipamorelin?

  • Most selective GHRP available
  • Minimal side effects vs GHRP-6, GHRP-2
  • Consistent GH release
  • No significant appetite increase
  • See our GHRP-6 guide for GHRP comparison.

    CJC-1295 Variants

    CJC-1295 with DAC:

    PropertyDetails
    Full NameCJC-1295 with Drug Affinity Complex
    TypeGHRH analog
    Half-life6-8 days
    MechanismAlbumin binding extends duration
    GH ReleaseSustained elevation
    DosingLess frequent (weekly)

    CJC-1295 without DAC (Mod GRF 1-29):

    PropertyDetails
    Full NameModified GRF 1-29
    TypeGHRH analog
    Half-life~30 minutes
    GH ReleasePulsatile, physiological
    DosingMultiple times daily
    PatternMimics natural GHRH

    Which CJC-1295 to Choose?

    With DAC:

  • Less frequent dosing
  • Sustained GH elevation
  • Higher baseline GH/IGF-1
  • May blunt natural pulses
  • Without DAC (Mod GRF 1-29):

  • More physiological pulsing
  • Preserves natural rhythm
  • Requires more frequent dosing
  • Preferred by many researchers
  • Research Applications

    Growth Hormone Studies

    GH Axis Research:

  • Pulsatile vs sustained release
  • IGF-1 response patterns
  • Somatotroph function
  • Feedback mechanisms
  • Metabolic Research:

  • Body composition effects
  • Lipid metabolism
  • Glucose handling
  • Protein synthesis
  • Comparative Studies

    Peptide Comparisons:

  • Single vs combination effects
  • Dose-response relationships
  • Optimal ratios
  • Timing optimization
  • Age-Related Research:

  • GH decline with aging
  • Response variation by age
  • Restoration potential
  • Dosing Protocols in Research

    Reconstitution

    Ipamorelin:

    Vial SizeBAC WaterConcentration
    2mg2ml1mg/ml
    5mg2.5ml2mg/ml

    CJC-1295 (either variant):

    Vial SizeBAC WaterConcentration
    2mg2ml1mg/ml
    5mg2.5ml2mg/ml

    Use our peptide calculator for precise measurements.

    CJC-1295 + Ipamorelin

    CJC-1295 + Ipamorelin

    5mg each99%+ Purity

    $54.99

    In Stock

    Stack Timing

    With DAC (CJC-1295 DAC):

  • CJC-1295 DAC: Once weekly
  • Ipamorelin: Multiple times daily
  • Less coordination needed
  • Enjoying this article?

    Subscribe to get notified when we publish new experiment reports and research findings.

    No spam, unsubscribe anytime.

    Without DAC (Mod GRF 1-29):

  • Both administered together
  • Typical: 2-3 times daily
  • Fasted state preferred
  • 30 min before meals or at bedtime
  • Research Dosing Ranges

    Literature References:

  • Ipamorelin: 100-300mcg per administration
  • CJC-1295 (no DAC): 100-300mcg per administration
  • CJC-1295 DAC: 1000-2000mcg weekly
  • Specific protocols should follow institutional guidelines.

    GH Response Optimization

    Factors Enhancing Response

    Timing:

  • Fasted state (no food 2 hours prior)
  • Morning administration
  • Pre-sleep administration (mimics natural peak)
  • Lifestyle:

  • Adequate sleep
  • Exercise (resistance training)
  • Controlled carbohydrate intake
  • Physiological:

  • Lower body fat percentage
  • Younger age (typically higher response)
  • Adequate baseline nutrition
  • Factors Blunting Response

    Avoid:

  • High-fat meals before dosing
  • Elevated blood glucose
  • Excessive frequency (desensitization)
  • Poor sleep quality
  • Stack Comparisons

    Ipamorelin/CJC-1295 vs Single Peptides

    ProtocolGH ReleaseConveniencePhysiological
    Ipamorelin aloneModerateHighYes
    CJC-1295 aloneModerateHighModerate
    CombinationHighModerateYes

    vs Other GH Peptides

    Stack/PeptideStrengthSelectivitySide Effects
    Ipamorelin + CJCHighExcellentMinimal
    GHRP-6 + CJCVery HighModerateAppetite, cortisol
    GHRP-2 + CJCVery HighLowCortisol, prolactin
    Ipamorelin aloneModerateExcellentMinimal

    Storage Guidelines

    Lyophilized (Both Peptides)

  • Freezer (-20°C): 2+ years
  • Refrigerator (2-8°C): 6-12 months
  • Protect from: Light, moisture
  • Reconstituted

  • Temperature: 2-8°C
  • Duration: 4-6 weeks
  • Do not mix: Keep in separate vials
  • Never freeze: Reconstituted solution
  • See our storage guide.

    Safety Profile

    Research Observations

    Ipamorelin:

  • Highly selective
  • Minimal cortisol elevation
  • Minimal prolactin elevation
  • No significant appetite increase
  • Well-tolerated in studies
  • CJC-1295:

  • Generally well-tolerated
  • Injection site reactions possible
  • Water retention reported (especially DAC)
  • Flushing/warmth after injection
  • Stack Considerations

  • Combined effects are additive
  • No unexpected interactions documented
  • Quality and purity essential
  • Monitoring protocols recommended
  • Frequently Asked Questions

    Why combine Ipamorelin with CJC-1295?

    They work through different receptors and pathways. Ipamorelin initiates GH pulses via the ghrelin receptor while CJC-1295 amplifies pulses via the GHRH receptor. Combined, they produce synergistic GH release mimicking natural physiology.

    Should I use CJC-1295 with or without DAC?

    Without DAC (Mod GRF 1-29) provides more physiological pulsatile release and preserves natural GH rhythm. With DAC provides sustained elevation and less frequent dosing. Most researchers prefer without DAC for physiological studies.

    Why choose Ipamorelin over GHRP-6 or GHRP-2?

    Ipamorelin is the most selective GHRP, causing GH release without significantly affecting cortisol, prolactin, or appetite. GHRP-6 causes strong hunger; GHRP-2 elevates cortisol and prolactin. For cleaner GH studies, Ipamorelin is preferred.

    What is the best time to administer the stack?

    Fasted conditions produce the best GH response—typically first thing in the morning before breakfast or at bedtime. Avoid administration within 2 hours of eating, especially high-fat or high-carbohydrate meals.

    How long until effects are observed?

    GH elevation occurs within 15-30 minutes of administration. Downstream effects (IGF-1 elevation, body composition changes) develop over weeks in research settings. Acute GH response is immediate.

    Can this stack be used with other peptides?

    Research has examined various combinations. The Ipamorelin/CJC-1295 stack is often considered foundational for GH research. Additional peptides depend on specific research goals. Consult relevant literature.

    Related Resources

  • GHRP-6 Guide - GHRP comparison
  • Ipamorelin Guide - Individual peptide
  • CJC-1295 Guide - Individual peptide
  • Peptide Calculator - Accurate dosing
  • Peptide Planner - Protocol design
  • Conclusion

    The Ipamorelin and CJC-1295 combination remains a gold standard for growth hormone research due to its synergistic mechanism, excellent selectivity, and minimal side effects. By engaging both arms of the GH-releasing pathway, researchers can achieve robust, physiological GH secretion.

    Whether studying GH physiology, age-related decline, or metabolic effects, this stack provides a well-characterized tool with extensive literature support.


    This article is for informational purposes only. These peptides are sold for research purposes and are not intended for human consumption. All research should be conducted in accordance with applicable regulations.

    Found this useful? Share it with others!

    Share:
    Peptod

    Want More Experiment Reports?

    Check out our other self-experimentation reports or explore our learning resources.